TRI-MOXI PLUS Trademark

Trademark Overview

On Tuesday, December 28, 2021, a trademark application was filed for TRI-MOXI PLUS with the United States Patent and Trademark Office. The USPTO has given the TRI-MOXI PLUS trademark a serial number of 97193506. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 6, 2025. This trademark is owned by Harrow IP, LLC. The TRI-MOXI PLUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical compositions for ocular or intraocular surgery
tri-moxi plus

General Information

Serial Number97193506
Word MarkTRI-MOXI PLUS
Filing DateTuesday, December 28, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 6, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 5, 2022

Trademark Statements

Goods and ServicesPharmaceutical compositions for ocular or intraocular surgery

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 4, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHarrow IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205
Party NameHarrow IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNashville, TN 37205

Trademark Events

Event DateEvent Description
Friday, December 31, 2021NEW APPLICATION ENTERED
Tuesday, January 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 28, 2022ASSIGNED TO EXAMINER
Monday, February 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 5, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 5, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 31, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2022SOU EXTENSION 1 FILED
Wednesday, November 30, 2022SOU EXTENSION 1 GRANTED
Friday, December 2, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 12, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, May 25, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 25, 2023SOU EXTENSION 2 FILED
Thursday, May 25, 2023SOU EXTENSION 2 GRANTED
Saturday, May 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2023SOU EXTENSION 3 FILED
Thursday, November 30, 2023SOU EXTENSION 3 GRANTED
Saturday, December 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 10, 2024SOU TEAS EXTENSION RECEIVED
Friday, May 10, 2024SOU EXTENSION 4 GRANTED
Friday, May 10, 2024SOU EXTENSION 4 FILED
Saturday, May 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 6, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, January 6, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

plus moxi surgery intraocular ocular compositions pharmaceutical